Published in Medical Letter on the CDC and FDA, March 16th, 1998
The U.S. Food and Drug Administration (FDA) and Hoffmann-La Roche, Nutley, New Jersey, said they had received reports of depression and suicide in teenagers taking Accutane, its prescription product for severe acne.
"Although the Accutane label already included information regarding depression as a possible adverse reaction, the agency felt healthcare providers and others needed additional information as a result of severe adverse event reports the agency has received," the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.